Comparison of Orcinoside With Placebo in Treatment of MDD

NCT02191384 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: Orcinoside

Sponsor

Shanghai Mental Health Center

Collaborators

[object Object]